Inactive Instrument
Abliva AB Stock
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 10/01/2014 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/2023 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 06/11/2017 | |
| Director/Board Member | 66 | 27/04/2017 | |
David Bejker
BRD | Director/Board Member | 51 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/03/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 07/03/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 12/02/25 | Sell | Founder | 277,850 | 0.0172% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 76M | |
| -1.09% | -2.03% | +54.08% | +55.43% | 53.83B | |
| -7.17% | -4.39% | +42.72% | +73.70% | 52.1B | |
| +0.80% | -6.31% | +5.62% | +413.12% | 23.48B | |
| -0.09% | -0.01% | -16.85% | -16.17% | 23.13B | |
| +3.46% | +2.52% | +36.64% | -5.41% | 19.36B | |
| -0.13% | -1.89% | +34.21% | -32.56% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +291.24% | 15.2B | |
| +3.62% | 0.00% | +33.47% | +643.91% | 14.83B | |
| +0.43% | -1.03% | +25.75% | +186.18% | 14.06B | |
| Average | -0.51% | -2.62% | +42.68% | +178.83% | 25.95B | |
| Weighted average by Cap. | -1.57% | -2.36% | +41.14% | +137.29% |
Employees
6
